Collplant Biotechnologies Ltd (CLGN)

NASDAQ
6.59
+1.38(+26.49%)
After Hours
6.33
-0.26(-3.95%)
- Real-time Data
  • Volume:
    27,003
  • Day's Range:
    5.24 - 6.66
  • 52 wk Range:
    4.27 - 18.30

CLGN Overview

Prev. Close
5.21
Day's Range
5.24-6.66
Revenue
629K
Open
5.32
52 wk Range
4.27-18.3
EPS
-1.49
Volume
27,003
Market Cap
57.76M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
16,314
P/E Ratio
-3.37
Beta
1.01
1-Year Change
-62.23%
Shares Outstanding
11,086,481
Next Earnings Date
Mar 23, 2023
What is your sentiment on Collplant ADR?
or
Market is currently closed. Voting is open during market hours.

Collplant Biotechnologies Ltd News

Collplant Biotechnologies Ltd Analysis

Collplant Biotechnologies Ltd Company Profile

Collplant Biotechnologies Ltd Company Profile

Employees
66

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company’s products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel’s Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Read More

Analyst Price Target

Average17.00 (+157.97% Upside)
High17
Low17
Price6.59
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Love this panic...please drop 30% more
    0
    • Guys check CELLINK, great swedish 3D bioprinting company with big growth year after year.
      0